X

Vous n'êtes pas connecté

Articles similaires

Breast cancer survivors less likely to develop Alzheimer’s in five years post-cancer survival

thewest.com.au - 21/Jun 18:00

Survivors of breast cancer may be less likely to develop Alzheimer’s disease in the years following treatment.

Breast cancer survivors less likely to develop Alzheimer’s in five years post-cancer survival

thewest.com.au - 21/Jun 18:00

Survivors of breast cancer may be less likely to develop Alzheimer’s disease in the years following treatment.

Auckland woman paying $85k for cancer treatment petitions Government for funding

nzherald.co.nz - 27/Jun 01:00

Catherine Cooke petitions Govt to fund Keytruda for early triple negative breast cancer.

Auckland woman paying $85k for cancer treatment petitions Government for funding

nzherald.co.nz - 27/Jun 01:00

Catherine Cooke petitions Govt to fund Keytruda for early triple negative breast cancer.

Could AI Understand Your Tumour Better Than a Doctor?

medindia.net - 27/Jun 02:10

New AI tool, maps cancer cell diversity into five key types, unlocking the potential for personalized treatment and improved outcomes in breast...

Sorry! Image not available at this time

Jessie J gives update after breast cancer surgery

wn.com - 24/Jun 07:32

Jessie J has shared an update on the "lows and highs" of her breast cancer journey following her surgery. The Price Tag singer announced in early June...

Sorry! Image not available at this time

Jessie J gives update after breast cancer surgery

wn.com - 24/Jun 07:32

Jessie J has shared an update on the "lows and highs" of her breast cancer journey following her surgery. The Price Tag singer announced in early June...

Sorry! Image not available at this time

ESR1 Mutated Metastatic Breast Cancer Diagnostics Market to Grow to USD 92.9M by 2035

wn.com - 24/Jun 07:32

The ESR1 mutated metastatic breast cancer diagnostics market is valued at USD 64.61 million in 2025 and is slated to reach USD 92.92 million by 2035,...

Sorry! Image not available at this time

ESR1 Mutated Metastatic Breast Cancer Diagnostics Market to Grow to USD 92.9M by 2035

wn.com - 24/Jun 07:32

The ESR1 mutated metastatic breast cancer diagnostics market is valued at USD 64.61 million in 2025 and is slated to reach USD 92.92 million by 2035,...

How Vitamin D Could Supercharge Chemotherapy in Breast Cancer Treatment

medindia.net - 21/Jun 20:54

A recent study from the Botucatu School of Medicine at Sao Paulo State University in Brazil found that supplementing with blow doses of vitamin D...

Les derniers communiqués